Abstract: Chronic lymphocytic leukemia (CLL) is a prevalent but incurable malignancy with a variable disease course. As the most common lymphoid malignancy in the United States, …
Abstract: We performed a retrospective chart review of 6266 randomly selected DLBCL patients treated in the VHA nationwide between 1/1/2011 and 12/31/2021. The 3178 patients who …
Abstract: Introduction: The standard treatment approach for DLBCL has traditionally relied on chemo-immunotherapy with R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine …